z-logo
open-access-imgOpen Access
Liver biopsy may not be the optimal option for assessing treatment efficacy in chronic hepatitis delta (CHD) infection
Author(s) -
Aysun Kartal,
Mehmet Berk Örüncü,
Berna Savaş,
Ramazan İdilman,
Fatma Yavas,
Cihan Yurdadin
Publication year - 2019
Publication title -
the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2019.44
Subject(s) - medicine , chronic hepatitis , liver biopsy , biopsy , hepatitis delta , intensive care medicine , gastroenterology , virology , hepatitis b virus , virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom